Protein CEACAM1 Identified as Key Protector in Liver Transplants: Recent Study Unveils

Harnessing the power of CEACAM1-S could bring in a new era of safer and more successful liver transplants. By tapping into the intricate mechanisms that protect the liver from damage, scientists are taking significant strides towards improving the lives of countless patients awaiting life-changing organ transplants.

Liver transplantation is a complex and life-saving procedure, but it often comes with a risk of damaging the organ during the process. However, a recent study has uncovered a potential game-changer in this field. Scientists have identified a protein called CEACAM1 that plays a significant role in shielding the liver from harm during transplantation. This newfound understanding could pave the way for more successful procedures and improved outcomes for patients.


The research, conducted by a dedicated team of experts, has unveiled the molecular mechanisms underlying CEACAM1's protective abilities. By manipulating gene splicing and utilizing molecular tools, the researchers were able to enhance CEACAM1's protective effects. This promising approach led to reduced organ damage and better results after transplantation.


A crucial challenge during liver transplantation is the restoration of blood supply to an organ that previously had no oxygen. This process, while necessary, can trigger inflammation and tissue damage, commonly known as ischemic reperfusion injury. This study shed light on a potential solution to this problem, offering hope for minimizing this harm.


One of the key players identified in this study is Hypoxia Inducible Factor 1 (HIF-1), a protein responsible for regulating oxygen consumption. The researchers found that HIF-1 plays a pivotal role in activating CEACAM1-S, a specific version of CEACAM1 that helps limit cellular injury and enhance liver function in mice. Remarkably, the connection between CEACAM1-S and HIF-1 also proved to be a predictor of successful liver transplantation outcomes and improved immune function in human donor livers.


The study revealed an intriguing gene expression pathway called alternative splicing, which cells activate in response to oxygen stress and danger. This pathway enables cells to increase protein diversity, aiding in coping with inflammation and injury. When cells sense low oxygen levels, HIF-1 steps in to regulate a key RNA splicing factor called Polypyrimidine tract-binding protein 1 (Ptbp1). This regulation directs the splicing of the CEACAM1 gene, resulting in the protective CEACAM1-S version that helps mitigate liver injury caused by transplantation.


Excitingly, the researchers conducted animal studies using a molecule called DMOG to stabilize HIF-1 even under normal oxygen conditions. This approach effectively boosted the protective CEACAM1-S version, showcasing a potential therapeutic method for future investigations.


The potential of CEACAM1-S doesn't stop there. It could serve as a marker of liver quality and might offer therapeutic benefits for transplantation or acute liver injury. The researchers are now focusing on testing this concept by studying tissue perfusion in suboptimal human livers that were preserved under extended cold storage conditions.


The study's lead author, Kenneth Dery, expressed enthusiasm about the future possibilities. He noted that numerous genes likely undergo alternative splicing in response to the stress of liver transplantation. By comprehensively understanding these splicing changes, researchers hope to rejuvenate donor organs and alleviate organ shortages, ultimately revolutionizing the field of transplantation.


This groundbreaking study suggests that harnessing the power of CEACAM1-S could bring in a new era of safer and more successful liver transplants. By tapping into the intricate mechanisms that protect the liver from damage, scientists are taking significant strides towards improving the lives of countless patients awaiting life-changing organ transplants.

This study’s findings were published online in Science Translational Medicine.

Tags : #

About the Author

Sunny Parayan

Hey there! I'm Sunny, a passionate writer with a strong interest in the healthcare domain! When I'm not typing on my keyboard, I watch shows and listen to music. I hope that through my work, I can make a positive impact on people's lives by helping them live happier and healthier.

View Profile

Related Stories

Loading Please wait...


Trending Now

FLO organised a unique program at Bansilalpet Step-wellMarch 01, 2024
Dr Raj Nagarkar Achieves Milestone As India's 1st & World’s 3rd Oncosurgeon To Perform Robotic Lobectomy With VersiusMarch 01, 2024
IIIT Hyderabad receives grant from Qualcomm to fund and support Edge AI ResearchMarch 01, 2024
FORSYS Inc opens new office in financial districtFebruary 29, 2024
The Rise in Patients Requiring Revision Hip Replacement SurgeryFebruary 29, 2024
Aakash Launches Study Material in BengaliFebruary 29, 2024
Harmony in Action: Nisarg Srishti's Dual Impact Initiative Unleashes a Symphony of Change at Sane Guruji Shikshan Sanshtha, Pragati VidyalayaFebruary 29, 2024
Wearable Tech in the Bedroom: Introducing Loop, MyMuse’s Vibrating Ring Massager for MenFebruary 28, 2024
TechInvention Lifecare announces the ground breaking of its state-of-the-art Global Collaborative Centre for Medical Countermeasures February 28, 2024
Endocrine Disorders: Causes, Tests And TreatmentFebruary 28, 2024
Çelebi Delhi Cargo Terminal Management Bolsters Security and Efficiency with "CargoCEL," Barcode Scanning UpgradeFebruary 28, 2024
Venkaiah Naidu unveiled a book “There I Was” authored by Mrs Aruna Ravi KumarFebruary 27, 2024
Maxivision Super Specialty Eye Hospitals introduces Schwind Amaris 500, a state-of-the-art German InnovationFebruary 27, 2024
Maximising circular economy strategies for rare earth elements supplyFebruary 27, 2024
FICCI Ladies Organization organised an interaction with one of the doyens of the Indian IT industry Dr BVR Mohan ReddyFebruary 27, 2024
Nat Habit strengthens leadership to accelerate its growth journey to 500 Cr; onboards Ankita Srivastava (ex-L’Oreal, Reckitt, Marico, Raymond Consumer Care) as Chief Marketing OfficerFebruary 27, 2024
Shiprocket Launches Aarambh 2024 for Women-Led SMEs NationwideFebruary 27, 2024
Treatment is prevention: Stop the spread of infection by finding all and treating all TBFebruary 27, 2024
Advancing Healthcare Access: ScreenHer initiative in Pakistan close to reaching milestone of 20,000 diabetes screenings in 70 clinics February 26, 2024
FICCI Ladies Organization organized an interaction with one of the doyens of Indian IT industry Dr BVR Mohan ReddyFebruary 26, 2024